Description

22,24,25,28-Tetrahydroxy-4-(Hydroxymethyl)-14-Methyl-9β,19-Cyclo-5α-Ergostan-3-One is a highly functionalized ergostane-type steroid derivative, recognized for its complex hydroxylated structure which serves as a critical intermediate in advanced organic synthesis. This compound matters for its role as a key building block in the research and development of novel pharmaceutical agents, particularly in the exploration of steroidal drugs with modified biological activity. It is primarily needed by research institutions and pharmaceutical companies engaged in synthetic chemistry, medicinal chemistry, and the development of new therapeutic compounds targeting specific metabolic pathways.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the multi-step synthesis of novel steroidal drugs and active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies to develop new therapeutic agents with potential anti-inflammatory, hormonal, or metabolic activity.
• Biochemical Research: Employed in studies investigating sterol biosynthesis pathways and enzyme interactions due to its specific hydroxylation pattern.
• Reference Standard: Acts as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Advanced Organic Synthesis: Utilized as a complex starting material for the synthesis of other specialized steroidal compounds and natural product analogs.

Basic Information

Product Name	22,24,25,28-Tetrahydroxy-4-(Hydroxymethyl)-14-Methyl-9β,19-Cyclo-5α-Ergostan-3-One
CAS No.	70237-87-5
Molecular Formula	C₂₉H₄₈O₆
Molecular Weight	492.69 g/mol
Synonyms	22,24,25,28-Tetrahydroxy-4-(hydroxymethyl)-14-methyl-9β,19-cyclo-5α-ergostan-3-one; (22R,24S)-22,24,25,28-Tetrahydroxy-4-(hydroxymethyl)-14-methyl-9β,19-cyclo-5α-ergostan-3-one; 9β,19-Cyclo-5α-ergostane-3,22,24,25,28-pentol, 4-(hydroxymethyl)-14-methyl-3-one; A derivative of Cycloartenol; Tetrahydroxy-hydroxymethyl-methyl-cycloergostanone
EINECS	Contact for details

Quality Control

Our 22,24,25,28-Tetrahydroxy-4-(Hydroxymethyl)-14-Methyl-9β,19-Cyclo-5α-Ergostan-3-One is produced under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for research and pharmaceutical development. Certificates of Analysis (COA) detailing batch-specific results are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 95.0%
Loss on Drying	≤ 2.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.